glutathione and triple negative breast cancer Metabolic interplay between exogenous cystine glutamine dependence in triple-negative Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for
Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Heterogeneity and transcriptional drivers of triple negative breast cancer: Cell Reports
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




